Evidence map›Paper›PMID 39833459›Full record

ArticleScientific reports2025

Diagnostic accuracy of human papillomavirus testing on self-collected samples among women referred for colposcopy.

ChunX Yan, Jiong Ma, Xia Zheng, Jing Shu, XiaoJ Wang, XiaoY Chen, Feng Gao, XiaoQ Li, ShanQ M, LongM Huang and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

ChunX YanThe Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jiong MaThe Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xia ZhengThe Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jing ShuZhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
XiaoJ WangZhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
XiaoY ChenZhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
Feng GaoZhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.
XiaoQ LiHangzhou New Horizon Health Technology Co., Ltd, Hangzhou, Zhejiang, China.
ShanQ MHangzhou New Horizon Health Technology Co., Ltd, Hangzhou, Zhejiang, China.
LongM HuangHangzhou New Horizon Health Technology Co., Ltd, Hangzhou, Zhejiang, China.
XiaoT YuHangzhou New Horizon Health Technology Co., Ltd, Hangzhou, Zhejiang, China.
XueJ ChenThe Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. xuejunchen2024@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the diagnostic accuracy of self-collected urine and vaginal samples for the identification of precancerous cervical lesions in the referral population using high-risk human papillomavirus (hrHPV) assays based on polymerase chain reaction (PCR). It was a prospective study carried out in China from June 2021 to March 2022. The vaginal and urine samples were collected and analyzed by using a newly developed specific hrHPV PCR test, and matched cervical samples were analyzed by using an approved hrHPV DNA test. The primary outcomes were sensitivity for cervical intraepithelial neoplasia 2 or greater (CIN2 +). The secondary outcome was the accuracy of hrHPV findings in urine and vaginal samples compared to cervical samples. A total of 1,701 women were recruited with 113 women excluded. Among 1,588 qualified participants, a total of 203 cases of the CIN2 + group were enrolled in the two centers. The sensitivity and specificity of HPV detection for CIN2 + in urine, vaginal and cervical samples were 86.70% and 36.46%, 90.64% and 30.54%, 93.60% and 26.14%, respectively. The urine sample performed lower sensitivity (p = 0.003) and higher specificity (p < 0.001) than the cervical sample. There was no difference in sensitivity between vaginal and cervical samples (p = 0.146), and the specificity of vaginal samples was higher than that in cervical samples (p < 0.001). The agreement was 78.15% of urine and cervical samples and 85.71% of vaginal and cervical samples. HPV testing on self-collected urine and vaginal samples has acceptable consistency compared with traditional cervical samples. It may be an alternative option for cervical cancer screening. Additional studies are still required to substantiate this issue.

Indexed as

PapillomaviridaePapillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsAdultCervix UteriChinaColposcopyDNA, ViralEarly Detection of CancerFemaleHuman Papillomavirus VirusesHumansMiddle AgedProspective StudiesSensitivity and SpecificityDNA, ViralCervical intraepithelial neoplasiaDiagnostic test accuracyHPV testingHuman papillomavirusSelf-samplingUrine

Identifiers

PMID39833459
PMCPMC11747457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.